Rchr
J-GLOBAL ID:200901057709089293   Update date: Jul. 14, 2024

Otsu Makoto

Otsu Makoto
Affiliation and department:
Research field  (1): Hematology and oncology
Research theme for competitive and other funds  (25):
  • 2018 - 2021 Establishment of induced pluripotent stem cells utilizing postmortem tissue derived following sudden death
  • 2018 - 2021 Study on regulation of lymphocyte development by IKZF family proteins and on molecular pathogenesis of disorders caused by a mutation in IKZF family molecules.
  • 2017 - 2021 NETs including oxidative mitochondria DNA might make worse the autoimmune-inflammation in CGD
  • 2017 - 2020 Studies necessary to establish ideal HSC gene therapy for Wiskott Aldrich Syndrome
  • 2017 - 2019 Development of hematopoietic stem cell products by using multiple cord blood units
Show all
Papers (68):
  • Bunki Natsumoto, Hirofumi Shoda, Yasuo Nagafuchi, Mineto Ota, Takashi Okumura, Yumi Horie, Tomohisa Okamura, Kazuhiko Yamamoto, Motonori Tsuji, Makoto Otsu, et al. Functional evaluation of rare OASL variants by analysis of SLE patient-derived iPSCs. Journal of autoimmunity. 2023. 139. 103085-103085
  • Mariko Watanabe, Hiromi Hatsuse, Kazuaki Nagao, Makoto Nakashima, Kaoru Uchimaru, Makoto Otsu, Koji Miyazaki, Ryouichi Horie. CD30 induces Reed-Sternberg cell-like morphology and chromosomal instability in classic Hodgkin lymphoma cell lines. Cancer science. 2023. 114. 8. 3433-3445
  • Makoto Otsu, Yuji Tanabe, Ayako Iwakiri, Kazuna Arima, Anna Uchiyama, Marina Yamamoto, Shinichi Ohtani, Hiroshi Endo, Mina Komoto, Koji Miyazaki. A report on a modified protocol for flow cytometry-based assessment of blood group erythrocyte antigens potentially suitable for analysis of weak ABO subgroups. Transfusion. 2023. 63. 3. 463-469
  • Toru Uchiyama, Sirirat Takahashi, Kazuhiko Nakabayashi, Kohji Okamura, Kaori Edasawa, Masafumi Yamada, Nobuyuki Watanabe, Emi Mochizuki, Toru Yasuda, Akane Miura, et al. Nonconditioned ADA-SCID gene therapy reveals ADA requirement in the hematopoietic system and clonal dominance of vector-marked clones. Molecular therapy. Methods & clinical development. 2021. 23. 424-433
  • Manabu Kawata, Daisuke Mori, Kosuke Kanke, Hironori Hojo, Shinsuke Ohba, Ung-Il Chung, Fumiko Yano, Hideki Masaki, Makoto Otsu, Hiromitsu Nakauchi, et al. Simple and Robust Differentiation of Human Pluripotent Stem Cells toward Chondrocytes by Two Small-Molecule Compounds. Stem cell reports. 2019. 13. 3. 530-544
more...
MISC (5):
  • Taku Saito, Fumiko Yano, Daisuke Mori, Manabu Kawata, Kazuto Hoshi, Tsuyoshi Takato, Hideki Masaki, Makoto Otsu, Koji Eto, Hiromitsu Nakauchi, et al. Hyaline cartilage formation and tumorigenesis of implanted tissues derived from human induced pluripotent stem cells. BIOMEDICAL RESEARCH-TOKYO. 2015. 36. 3. 179-186
  • Makoto Otsu, Nao Suzuki, Satoshi Yamazaki, Tomoyuki Yamaguchi, Motohito Okabe, Hideki Masaki, Satoshi Takaki, Hiromitsu Nakauchi. A possible therapeutic strategy for genetic diseases using hematopoietic stem cells generated from induced pluripotent stem cells. HUMAN GENE THERAPY. 2013. 24. 12. A41-A42
  • Taku Saito, Fumiko Yano, Daisuke Mori, Shinsuke Ohba, Hironori Hojo, Makoto Otsu, Koji Eto, Hiromitsu Nakauchi, Sakae Tanaka, Ung-il Chung, et al. Generation of Col2a1-EGFP iPS Cells for Monitoring Chondrogenic Differentiation. PLOS ONE. 2013. 8. 9
  • Mayumi Iwata-Okada, Torayuki Okuyama, Shin-ichi Kobayashi, Toshinao Kawai, Yasuomi Horiuchi, Nobutaka Kiyokawa, Xiao-Kang Li, Junichiro Fujimoto, Makoto Otsu, Akihiro Kume, et al. A REPORT OF THE PROGRESS FOR X-CGD GENE THERAPY IN JAPAN. JOURNAL OF GENE MEDICINE. 2010. 12. 12. 1057-1057
  • Yasuo Takeuchi, Makoto Otsu, Emiko Takeuchi, Sachie Suzuki, Shin Kaneko, Motihito Okabe, Akihiro Kume, Masafumi Onodera, Hiromitsu Nakauchi. Development of a safe and effective stem cell transplantation strategy by the use of antibody-based minimum intensity preconditioning and delayed infusion of suicide-gene transduced donor T lymphocytes in the mouse model of X-linked chronic granulomatous disease (X-CGD). HUMAN GENE THERAPY. 2008. 19. 10. 1184-1185
Professional career (1):
  • M.D., Ph.D. (Hokkaido University)
Association Membership(s) (10):
Japan Society of Gene and Cell Therapy ,  日本血液疾患免疫療法学会 ,  日本リウマチ学会 ,  米国遺伝子細胞治療学会 ,  米国血液学会 ,  日本免疫学会 ,  日本輸血・細胞治療学会 ,  日本検査血液学会 ,  日本小児科学会 ,  日本血液学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page